Reliance Life Sciences Private Limited: Pemetrexed For Injection 100mg/vial, 1
Pemetrexed for Injection Recall Summary Reliance Life Sciences is recalling Pemetrexed for Injection 100mg/Vial (NDC 70069-0834-01), a cancer medication manufactured for Somerset Therapeutics, due to lack of sterility assurance. The recall affects product distributed nationwide across all U.S. states and Washington, D.C. This is a Class II recall, meaning the product could cause serious health consequences or death.
- Recalling firm
- Reliance Life Sciences Private Limited
- Product
- Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01
- Reason
- Lack of Sterility Assurance
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-06-24
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/edd351ef-73f5-4403-9430-462fbfc7714e